Promising Therapeutic Strategies for Colorectal Cancer Treatment ...

Immunotherapy can be used to treat patients with advanced colorectal cancer. It has brought new hopes to cancer patients, as it promises a net improvement in ...

Graphene oxide is a promising 2D material found to play an important role in cancer treatments through several strategies: direct killing and ...

Recent Advances in Therapeutic Strategies to Improve Colorectal ...

FP-based doublet therapies in which 5-FU/LV is combined with oxaliplatin (FOLFOX) or irinotecan (FOLFIRI) are now a preferred first-line treatment for mCRC.

How to Treat Colorectal Cancer

Colorectal cancer can also be treated using drugs, which can be given by mouth or directly into the bloodstream. These are called systemic treatments because ...

Promising therapeutic strategies for colorectal cancer treatment

Neoadjuvant immunotherapy consisting of ipilimumab plus nivolumab has the potential to become a new standard-of-care in dMMR colon cancer.

Current and emerging therapeutic approaches for colorectal cancer

Immunotherapy as a promising candidate for CRC treatment: Following early breakthroughs in the treatment of melanoma, immunotherapy has been ...

A pioneering strategy in advancing colorectal cancer treatment

For colorectal cancer patients in the metastatic stage who are not able to undergo the previously reported conventional therapeutic modalities, namely ...

Update on Emerging Therapies for Advanced Colorectal Cancer

Anti-EGFR therapy in combination with chemotherapy is effective for patients with KRAS, NRAS, and BRAF wild-type and left-sided primary CRC ...

Advances in Colorectal Cancer Research - NCI

Treatment for Colorectal Cancer · Immunotherapy for patients with Lynch syndrome or MSI-H colorectal cancer · Combining immunotherapy with other ...

Current and Future Trends of Colorectal Cancer Treatment - MDPI

Immune checkpoint inhibitors (ICIs), adoptive cell therapy (ACT), chimeric antigen receptor (CAR) T-cell, tumor-infiltrating lymphocyte (TIL). 2. Genetic ...

Recent advances in nanomedicine preparative methods and their ...

The conventional treatments for CRC have a number of limitations. Nanoparticles have emerged as a promising cancer treatment method due to their ability to ...

New treatment alternatives for primary and metastatic colorectal ...

Metastatic colorectal cancer (CRC) is still in need of effective treatments. This study applies a holistic approach to propose new targets ...

Comprehensive review of targeted therapy for colorectal cancer

Targeted therapy is a new optional approach that has successfully prolonged overall survival for CRC patients. Following successes with the anti ...

Colorectal cancer therapy mediated by nanomedicines

In recent years, with the development of molecular biology of colorectal cancer, many promising therapeutic strategies based on nanomaterials have been ...

The future of effective diagnosis and treatment of colorectal cancer?

Drug delivery via NPs has shown promise in overcoming these hurdles(Lorscheider et al., 2020). Therapeutic agents currently used for CRC fall ...

Case report: A combined immunotherapy strategy as a promising ...

Nowadays, PD-L1 inhibitors or combined CTLA4 inhibitors are the major strategies for advanced or metastatic MSI-H colorectal cancer, but some ...

Combined targeting of HER-2 and HER-3 represents a promising ...

Abrogation of growth factor-dependent signaling represents an effective therapeutic strategy for patients with colorectal cancer (CRC).

Colorectal cancer treatment using bacteria: focus on molecular ...

The introduction of advanced and successful strategies in bacterial colorectal cancer therapy could be useful to identify new promising ...

5 Innovative Colorectal Cancer Treatment Options

Colorectal cancer treatment plans ... Colon cancer that has not spread to distant parts of the body is usually treated with surgery. Some patients then receive ...

Advances in Colorectal Cancer Treatments

In many cases, achieving further progress against these advanced-stage colorectal cancers will require using combinations of recently approved ...